Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (84)
- Cardiology (76)
- Medical Sciences (45)
- Public Health (23)
- Life Sciences (19)
-
- Internal Medicine (12)
- Endocrinology, Diabetes, and Metabolism (11)
- Oncology (10)
- Biomedical Informatics (9)
- Bioinformatics (8)
- Community Health and Preventive Medicine (7)
- Endocrine System Diseases (7)
- Biochemistry, Biophysics, and Structural Biology (6)
- Geriatrics (5)
- Medical Genetics (5)
- Biochemical Phenomena, Metabolism, and Nutrition (4)
- Social and Behavioral Sciences (4)
- Surgery (4)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (3)
- Chemicals and Drugs (3)
- Critical Care (3)
- Dietetics and Clinical Nutrition (3)
- Health Services Research (3)
- Investigative Techniques (3)
- Mental and Social Health (3)
- Neurosciences (3)
- Nutrition (3)
- Institution
- Publication Year
- Publication
-
- Faculty, Staff and Students Publications (30)
- Faculty, Staff and Student Publications (23)
- The Texas Heart Institute Journal (18)
- Division of Cardiology Faculty Papers (2)
- NYMC Faculty Publications (2)
-
- Rowan-Virtua Research Day (2)
- Rowan-Virtua School of Osteopathic Medicine Departmental Research (2)
- Department of Medicine Faculty Papers (1)
- Department of Rehabilitation Medicine Faculty Papers (1)
- Department of Surgery Faculty Papers (1)
- Doctor of Nursing Practice Projects (1)
- Internal Medicine Faculty Publications (1)
- Manuscripts, Articles, Book Chapters and Other Papers (1)
- Medical College Documents (1)
- Office of the President Publications and Research (1)
- Pharmacology and Nutritional Sciences Faculty Publications (1)
- Pharmacy Faculty Articles and Research (1)
- Pharmacy and Wellness Review (1)
- Research Symposium (1)
- Student Papers, Posters & Projects (1)
- Student Scholarly Projects (1)
- University of the Pacific Theses and Dissertations (1)
- Publication Type
Articles 91 - 94 of 94
Full-Text Articles in Cardiovascular Diseases
Internal Medicine Problems As They Present To The Cardiologist, Ira Martin Grais
Internal Medicine Problems As They Present To The Cardiologist, Ira Martin Grais
The Texas Heart Institute Journal
No abstract provided.
Cd34-Positive Stem Cells In The Treatment Of Heart And Vascular Disease In Human Beings, Alexander R Mackie, Douglas W Losordo
Cd34-Positive Stem Cells In The Treatment Of Heart And Vascular Disease In Human Beings, Alexander R Mackie, Douglas W Losordo
The Texas Heart Institute Journal
Bone marrow-derived CD34(+) cells are a well-characterized population of stem cells that have traditionally been used clinically to reconstitute the hematopoietic system after radiation or chemotherapy. More recently, CD34(+) cells have also been shown to induce therapeutic angiogenesis in animal models of myocardial, peripheral, and cerebral ischemia. The mechanism by which CD34(+) cells promote therapeutic angiogenesis is not completely understood, although evidence supports both direct incorporation of the cells into the expanding vasculature and paracrine secretion of angiogenic growth factors that support the developing microvasculature. Phase I and phase II clinical trials have explored the usefulness of CD34(+) cells in …
Transcriptional Control Of Vascular Smooth Muscle Cell Proliferation By Peroxisome Proliferator-Activated Receptor-Γ: Therapeutic Implications For Cardiovascular Diseases, Florence Gizard, Dennis Bruemmer
Transcriptional Control Of Vascular Smooth Muscle Cell Proliferation By Peroxisome Proliferator-Activated Receptor-Γ: Therapeutic Implications For Cardiovascular Diseases, Florence Gizard, Dennis Bruemmer
Internal Medicine Faculty Publications
Proliferation of vascular smooth muscle cells (SMCs) is a critical process for the development of atherosclerosis and complications of procedures used to treat atherosclerotic diseases, including postangioplasty restenosis, vein graft failure, and transplant vasculopathy. Peroxisome proliferator-activated receptor (PPAR) gamma is a member of the nuclear hormone receptor superfamily and the molecular target for the thiazolidinediones (TZD), used clinically to treat insulin resistance in patients with type 2 diabetes. In addition to their efficacy to improve insulin sensitivity, TZD exert a broad spectrum of pleiotropic beneficial effects on vascular gene expression programs. In SMCs, PPARgamma is prominently upregulated during neointima formation …
Stereospecific Pharmacokinetics And Pharmacodynamics Of Beta-Adrenergic Blockers In Humans, Reza Mehvar, Dion R. Brocks
Stereospecific Pharmacokinetics And Pharmacodynamics Of Beta-Adrenergic Blockers In Humans, Reza Mehvar, Dion R. Brocks
Pharmacy Faculty Articles and Research
The beta-blockers comprise a group of drugs that are mostly used to treat cardiovascular disorders such as hypertension, cardiac arrhythmia, or ischemic heart disease. Each of these drugs possesses at least one chiral center, and an inherent high degree of enantioselectivity in binding to the b-adrenergic receptor. For beta-blockers with a single chiral center, the (-) enantiomer possesses much greater affinity for binding to the b-adrenergic receptors than antipode. The enantiomers of some of these drugs possess other effects, such as antagonism at alpha-adrenergic receptors or Class III antiarrhythmic activity. However, these effects generally display a lower level of stereoselectivity …